Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050
Accelerating precision oncology by converging pragmatic trials and real-world evidence
Nat Rev Drug Discov (in press)
DOI 10.1038/d41573-025-00047-5, PubMed 40082591
Cyclic nucleotide phosphodiesterases as drug targets
Pharmacol Rev, 77 (3), 100042 (in press)
DOI 10.1016/j.pharmr.2025.100042, PubMed 40081105